Aurobindo Pharma Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aurobindo Pharma Limited's balance sheet done over the years? Its assets were worth $450,715,100,000 last year, which is more than in the previous period. 34% of Aurobindo Pharma Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $152,207,100,000, which means an increase by 63% compared compared to last year.
Debt to Assets
| 2011 | 58772400000 | 34.23B | 58.25% |
|---|---|---|---|
| 2012 | 62376300000 | 38.87B | 62.33% |
| 2015 | 129144800000 | 77.32B | 59.88% |
| 2016 | 156993500000 | 85.83B | 54.67% |
| 2018 | 211052000000 | 94.22B | 44.65% |
| 2019 | 264543700000 | 125.62B | 47.49% |
| 2020 | 289263500000 | 121.15B | 41.89% |
| 2021 | 338539900000 | 119.25B | 35.22% |
| 2022 | 339217200000 | 93.47B | 27.56% |
| 2024 | 450715100000 | 152.20B | 33.77% |
AUROPHARMA.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 33.93B | 41.62B | 53.73B | 27.63B | 18.55B | 11.94B | 8.32B | 4.67B | 708.6M | 1.88B |
Short term investments | 29.31B | 3.95B | 2.47B | 784.6M | 735M | 457.4M | 200K | 196.5M | 186.8M | 0 |
Net receivables | 48.16B | 44.56B | 37.26B | 43.84B | 59.64B | 30.80B | 50.78B | 40.26B | 0 | 0 |
Inventory | 98.08B | 75.53B | 90.26B | 76.99B | 72.45B | 58.58B | 40.88B | 36.11B | 15.45B | 14.55B |
Other current assets | 32.55B | 15.55B | 14.48B | 14.85B | 2.25B | 19.79B | 3.56B | 1.71B | 16.28B | 17.48B |
Total current assets | 242.05B | 181.22B | 198.23B | 164.12B | 153.64B | 121.87B | 100.01B | 82.98B | 32.64B | 33.92B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 144.11B | 106.65B | 93.15B | 81.16B | 70.35B | 61.36B | 43.92B | 32.72B | 25.87B | 17.38B |
Goodwill | 5.95B | 4.75B | 4.28B | 9.15B | 8.32B | 8.16B | 4.49B | 5.33B | 541.4M | 0 |
Intangible assets | 34.81B | 31.37B | 26.90B | 23.49B | 22.75B | 11.51B | 4.21B | 3.19B | 1.98B | 0 |
Long term investments | -22.02B | 6.18B | 4.31B | 5.54B | 2.88B | 2.67B | 1.2M | -195.1M | 11.8M | 0 |
Other non-current assets | 33.67B | 6.12B | 7.11B | 4.13B | 4.74B | 3.87B | 4.34B | 5.05B | 1.26B | 7.42B |
Total non-current assets | 208.65B | 157.99B | 140.30B | 125.13B | 110.89B | 89.17B | 56.97B | 46.15B | 29.73B | 24.85B |
Total assets | 450.71B | 339.21B | 338.53B | 289.26B | 264.54B | 211.05B | 156.99B | 129.14B | 62.37B | 58.77B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 2.70B | 26.13B | 26.43B | 26.9B | 25.34B | 16.41B | 10.17B | 9.53B | 0 | 0 |
Short term debt | 42.60B | 27.11B | 51.15B | 60.36B | 67.86B | 42.51B | 42.92B | 28.45B | 21.31B | 0 |
Total current liabilities | 121.99B | 81.55B | 106.65B | 113.86B | 120.42B | 86.80B | 74.75B | 61.36B | 29.15B | 8.86B |
| Non-current liabilities: | ||||||||||
Long term debt | 23.87B | 5.67B | 4.34B | 2.64B | 1.79B | 4.73B | 7.42B | 13.61B | 9.64B | 24.14B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.22B |
Other non-current liabilities | 2.41B | 297.7M | 395M | 874.8M | 113M | 445.1M | 4.95B | 2.34B | 42.4M | 0 |
Total non-current liabilities | 30.21B | 11.91B | 12.59B | 7.29B | 5.19B | 7.42B | 11.07B | 15.96B | 9.72B | 25.37B |
Total liabilities | 152.20B | 93.47B | 119.25B | 121.15B | 125.62B | 94.22B | 85.83B | 77.32B | 38.87B | 34.23B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |